|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Zhang Y, Duan G and Feng S: MicroRNA-301a
modulates doxorubicin resistance in osteosarcoma cells by targeting
AMP-activated protein kinase alpha 1. Biochem Biophys Res Commun.
459:367–373. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Xu M, Jin H, Xu CX, Sun B, Mao Z, Bi WZ
and Wang Y: miR-382 inhibits tumor growth and enhance
chemosensitivity in osteosarcoma. Oncotarget. 5:9472–9483. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Gillet JP and Gottesman MM: Overcoming
multidrug resistance in cancer: 35 years after the discovery of
ABCB1. Drug Resist Updat. 15:2–4. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
He Y, Wang Y, Liu H, Xu X, He S, Tang J,
Huang Y, Miao X, Wu Y, Wang Q, et al: Pyruvate kinase isoform M2
(PKM2) participates in multiple myeloma cell proliferation,
adhesion and chemoresistance. Leuk Res. 39:1428–1436. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhang W, Li Q, Song C and Lao L: Knockdown
of autophagy-related protein 6, Beclin-1, decreases cell growth,
invasion, and metastasis and has a positive effect on
chemotherapy-induced cytotoxicity in osteosarcoma cells. Tumour
Biol. 36:2531–2539. 2015. View Article : Google Scholar
|
|
7
|
Zhang R, Yan S, Wang J, Deng F, Guo Y, Li
Y, Fan M, Song Q, Liu H, Weng Y, et al: MiR-30a regulates the
proliferation, migration, and invasion of human osteosarcoma by
targeting Runx2. Tumour Biol. 2015.
|
|
8
|
Jin H and Wang W: MicroRNA-539 suppresses
osteosarcoma cell invasion and migration in vitro and targeting
Matrix metal-lopeptidase-8. Int J Clin Exp Pathol. 8:8075–8082.
2015.
|
|
9
|
Mori F, Sacconi A, Canu V, Ganci F,
Novello M, Anelli V, Covello R, Ferraresi V, Muti P, Biagini R, et
al: miR-181c associates with tumor relapse of high grade
osteosarcoma. Oncotarget. 6:13946–13961. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Rodriguez A, Griffiths-Jones S, Ashurst JL
and Bradley A: Identification of mammalian microRNA host genes and
transcription units. Genome Res. 14(10A): 1902–1910. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Wen XP, Ma HL, Zhao LY, Zhang W and Dang
CX: MiR-30a suppresses non-small cell lung cancer progression
through AKT signaling pathway by targeting IGF1R. Cell Mol Biol
(Noisy-le-grand). 61:78–85. 2015.
|
|
12
|
Fu J, Xu X, Kang L, Zhou L, Wang S, Lu J,
Cheng L, Fan Z, Yuan B, Tian P, et al: miR-30a suppresses breast
cancer cell proliferation and migration by targeting Eya2. Biochem
Biophys Res Commun. 445:314–319. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhang Q, Tang Q, Qin D, Yu L, Huang R, Lv
G, Zou Z, Jiang XC, Zou C, Liu W, et al: Role of microRNA 30a
targeting insulin receptor substrate 2 in colorectal tumorigenesis.
Mol Cell Biol. 35:988–1000. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wang HY, Li YY, Fu S, Wang XP, Huang MY,
Zhang X, Shao Q, Deng L, Zeng MS, Zeng YX, et al: MicroRNA-30a
promotes invasiveness and metastasis in vitro and in vivo through
epithelial-mesenchymal transition and results in poor survival of
nasopharyngeal carcinoma patients. Exp Biol Med (Maywood).
239:891–898. 2014. View Article : Google Scholar
|
|
15
|
Yang HZ, Ma Y, Zhou Y, Xu LM, Chen XJ,
Ding WB and Zou HB: Autophagy contributes to the enrichment and
survival of colorectal cancer stem cells under oxaliplatin
treatment. Cancer Lett. 361:128–136. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wu H, Huang S, Chen Z, Liu W, Zhou X and
Zhang D: Hypoxia-induced autophagy contributes to the invasion of
salivary adenoid cystic carcinoma through the HIF-1α/BNIP3
signaling pathway. Mol Med Rep. 12:6467–6474. 2015.PubMed/NCBI
|
|
17
|
Zhou J, Wu S, Chen Y, Zhao J, Zhang K,
Wang J and Chen S: microRNA-143 is associated with the survival of
ALDH1+CD133+ osteosarcoma cells and the
chemoresistance of osteosarcoma. Exp Biol Med (Maywood).
240:867–875. 2015. View Article : Google Scholar
|
|
18
|
Chang Z, Huo L, Li K, Wu Y and Hu Z:
Blocked autophagy by miR-101 enhances osteosarcoma cell
chemosensitivity in vitro. Sci World J. 2014:7947562014. View Article : Google Scholar
|
|
19
|
Guo S, Bai R, Liu W, Zhao A, Zhao Z, Wang
Y, Wang Y, Zhao W and Wang W: miR-22 inhibits osteosarcoma cell
proliferation and migration by targeting HMGB1 and inhibiting
HMGB1-mediated autophagy. Tumour Biol. 35:7025–7034. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Zhou X, Yuan B, Yuan W, Wang C, Gao R and
Wang J: The expression and clinical significance of high mobility
group nucleosome binding domain 5 in human osteosarcoma. Tumour
Biol. 35:6539–6547. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhao H, Li M, Li L, Yang X, Lan G and
Zhang Y: MiR-133b is down-regulated in human osteosarcoma and
inhibits osteosarcoma cells proliferation, migration and invasion,
and promotes apoptosis. PLoS One. 8:e835712013. View Article : Google Scholar
|
|
22
|
Zou Z, Wu L, Ding H, Wang Y, Zhang Y, Chen
X, Chen X, Zhang CY, Zhang Q and Zen K: MicroRNA-30a sensitizes
tumor cells to cis-platinum via suppressing beclin 1-mediated
autophagy. J Biol Chem. 287:4148–4156. 2012. View Article : Google Scholar :
|
|
23
|
Luetke A, Meyers PA, Lewis I and Juergens
H: Osteosarcoma treatment - where do we stand? A state of the art
review. Cancer Treat Rev. 40:523–532. 2014. View Article : Google Scholar
|
|
24
|
Huang J, Ni J, Liu K, Yu Y, Xie M, Kang R,
Vernon P, Cao L and Tang D: HMGB1 promotes drug resistance in
osteosarcoma. Cancer Res. 72:230–238. 2012. View Article : Google Scholar
|
|
25
|
Pan B, Feng B, Chen Y, Huang G, Wang R,
Chen L and Song H: MiR-200b regulates autophagy associated with
chemoresistance in human lung adenocarcinoma. Oncotarget.
6:32805–32820. 2015.PubMed/NCBI
|
|
26
|
Ran X, Yang J, Liu C, Zhou P, Xiao L and
Zhang K: MiR-218 inhibits HMGB1-mediated autophagy in endometrial
carcinoma cells during chemotherapy. Int J Clin Exp Pathol.
8:6617–6626. 2015.PubMed/NCBI
|
|
27
|
Shteingauz A, Boyango I, Naroditsky I,
Hammond E, Gruber M, Doweck I, Ilan N and Vlodavsky I: Heparanase
enhances tumor growth and chemoresistance by promoting autophagy.
Cancer Res. 75:3946–3957. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Chen Z, Wang T, Liu Z, Zhang G, Wang J,
Feng S and Liang J: Inhibition of autophagy by miR-30A induced by
mycobacteria tuberculosis as a possible mechanism of immune escape
in human macrophages. Jpn J Infect Dis. 68:420–424. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Wang L, Zhang H, Sun M, Yin Z and Qian J:
high mobility group box 1-mediated autophagy promotes neuroblastoma
cell chemoresistance. Oncol Rep. 34:2969–2976. 2015.PubMed/NCBI
|
|
30
|
Zhu H, Wu H, Liu X, Li B, Chen Y, Ren X,
Liu CG and Yang JM: Regulation of autophagy by a beclin 1-targeted
microRNA, miR-30a, in cancer cells. Autophagy. 5:816–823. 2009.
View Article : Google Scholar : PubMed/NCBI
|
